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Editor, 
The emergence of the novel H1N1 influenza virus resulted 
in numerous infected children. There appears to have been 
an increase in the likelihood of an intensive care admission 
particularly for pregnant women. We report the first United 
Kingdom case of acute necrotising encephalitis (ANE) in a 
child associated with the H1N1 virus.
A healthy 4 year old Caucasian girl presented to hospital 
with seizures.  She had a 48 hour history of low grade fever, 
vomiting and rhinorrhoea.  On admission, she was febrile 
(38.9°C) and was observed to have a herpetic lesion on her 
lip.  She was fully immunised as per the UK schedule with 
no infectious contacts and an unremarkable family history. 
She remained in generalised status epilepticus despite 
benzodiazepine therapy.  She received an intravenous load of 
phenytoin and was intubated and ventilated.  Her initial blood 
results showed a white cell count of 14.7 x 109 (neutrophils 
10.9 x 109, lymphocytes 3.2 x 109), C reactive protein of 
31mg/L, glucose 8.2mmol/L, normal renal, liver function and 
coagulation.  She was given intravenous aciclovir, ceftriaxone 
and oral oseltamivir.  A lumbar puncture demonstrated a 
cerebrospinal fluid (CSF) opening pressure of 38cm water.   
CSF was acellular with protein 0.53g/L (normal range 0.10-
0.38g/L) and glucose 3.6mmol/L.  
She had an unenhanced Computerised Tomography (CT) 
brain examination, which was unremarkable except for mild 
cerebral swelling and some subtle low density change in the 
thalami. A Magnetic Resonance Imaging (MRI) examination 
was recommended to clarify further.  
She had no further seizures and was extubated the next 
morning.  She remained encephalopathic with lower limb 
hypertonia, hyperreflexia and upgoing plantars and required 
reintubation.  MRI brain scan on day 3 revealed symmetrical 
high signal changes on T2 weighted and Fluid Attenuation 
and Inversion Recovery (FLAIR) images involving the dentate 
nuclei, dorsal pons, midbrain and thalami with subcortical 
white matter high signal predominantly in the parietal and 
occipital regions (Figures 1 and 2).  No abnormal contrast 
enhancement was observed. On diffusion weighted imaging 
(DWI), only minor patchy diffusion restriction was noted 
in the cerebral white matter, but the thalami, brain stem or 
cerebellum did not show any evidence of diffusion restriction. 
T2-weighted gradient echo images did not show any evidence 
of haemorrhage. Electroencephalogram was encephalopathic 
with no epileptiform activity.  
Throat swab and broncho-alveolar lavage returned positive for 
H1N1 by RNA PCR.  CSF was negative for H1N1 by PCR.   
All other plasma and CSF serology were negative.  Scrapings 
of her lip lesion were positive for Herpes Simplex Virus 
Type 1.  Serial platelet count, liver function and coagulation 
remained within normal limits. 
The clinical and imaging findings were compatible with 
acute necrotizing encephalopathy (ANE).  She was treated 
with intravenous immunoglobulin on day 4 (2g/kg over 2 
days) and intravenous zanamivir on day 5 (20mg/kg for 5 
days).  This was made available on a compassionate basis 
from GlaxoSmithKline.  She made a rapid recovery and 
neurological examination at day 8 was completely normal.
discussion
ANE was first described in 1995 by Mizuguchi et al in Japan1.  
ANE is an acute onset encephalopathy which often presents 
with characteristic neuroimaging features of multiple, 
symmetrical deep grey-matter lesions involving the thalami, 
cerebral white matter, internal capsule, putamen, upper 
brainstem tegmentum  cerebellum and medulla2.  
Figure 1. Axial T2-weighted and FLAIR images at the level of the 
basal ganglia show T2 hyperintensity and swelling of the thalami 
(long arrows) and cortical/subcortical high signal within the 
parieto-occipital regions bilaterally (short arrows).
Figure 2. Axial T2-weighted and FLAIR images at the level of the 
pons show T2 hyperintensity within the pontine tegmentum (long 
arrows) and dentate nuclei bilaterally (short arrows).© The Ulster Medical Society, 2011.
50 The Ulster Medical Journal
www.ums.ac.uk
ANE has been associated most commonly with influenza A 
and B viruses2.  To the authors’ knowledge, this is the first 
childhood case in the United Kingdom of ANE in association 
with novel H1N1 virus.
There are few reports of neurological complications of H1N1 
in children.  In 2009, Evans et al in Texas reported 4 children 
with influenza like illness, seizures and altered mental state.   
They had H1N1 positive nasopharyngeal aspirates although no 
evidence of infection within the CSF.  Electroencephalograms 
in 3 patients were abnormal.  Neuroimaging in all 4 showed 
non-specific changes and no suggestion of ANE.  All 4 
patients recovered with no neurological sequelae at discharge3. 
More recently, there have been a few published cases of ANE 
during the current H1N1 pandemic, with imaging findings 
similar to our case, both from Europe/Eurasia4,5 and North 
America6,7. The rapid neurological deterioration with a 
minimal respiratory prodrome and seizures described in 
these reports was comparable to the case we present.  These 
case reports also describe a similar pattern of involvement 
of the thalami, dorsal brain stem and cerebellum, with 
variable involvement of the cerebral white matter, except for 
the case described by Haktanir5 where there was bithalamic 
and perirolandic cortical involvement. This case report had 
limited clinical information but appears to have presented in 
a similar way to the others. MRI findings in the case report 
describing fatality by Martin et al6, showed extensive white 
matter change and cerebral swelling, presumably leading to 
raised intracranial pressure and herniation, findings that were 
much less extensive in our patient. Ornitti et al4 describe 
diffusion restriction with haemorrhage in the thalami and 
diffusion restriction in the cerebellum and white matter, which 
presumably explains the residual damage noted on follow 
up and the protracted neurological recovery. Although we 
do not have radiological follow up in our case, the absence 
of restricted diffusion or haemorrhage within the thalami, 
brain stem or cerebellum on the day 3 MRI, together with the 
prompt clinical recovery, would probably indicate less severe 
residual damage in these areas, if any.
ANE has not been universally associated with a good 
outcome.  In a Japanese review of 89 children with ANE, 53 
(59.6%) had proven influenza virus.  Thirty-three (37.1%) 
died and 17(19.1%) had neurological sequelae8. Elevated 
interleukin six has been associated with adverse neurological 
outcome in the Japanese literature on ANE, it was elevated at 
441pg/ml in this case however it is of uncertain significance 
as other interleukins were also elevated. One possible 
explanation is sample transit time.
Unlike other reported cases, this child did not have CSF 
pleocytosis, abnormal liver function or coagulopathy.   
However, she did have a raised CSF protein which is typical.   
It has been suggested that children with normal CSF protein 
and liver function tend to recover well.  Normal CSF protein 
seems to have the strongest correlation to a good outcome9.  
Correlation of MRI findings and clinical outcomes has 
resulted in the development of a radiological scoring 
system which may be helpful.10 The possibility of familial 
encephalitis was considered in this case but there was no 
relevant family history.
There is no specific therapy for ANE.  Corticosteroids, 
dexamethasone, intravenous methylprednisolone, intravenous 
immunoglobulin and plasmapharesis have been used in 
different centres with variable long term outcomes9.  In 
this case, intravenous immunoglobulin was given for its 
potentially beneficial non-specific immunemodulatory 
effects.  This decision was aided further by the reluctance to 
use steroids in the presence of Herpes Simplex type 1 virus 
positive skin lesion. Other similar cases published recently 
have demonstrated ongoing neurological deficits.4,5
Intravenous zanamivir is an unlicensed treatment with 
currently unknown efficacy and has not been described in 
other published case reports of ANE associated with H1N1 
in children.  In this case, given the clinical and neuroimaging 
findings supporting a diagnosis of ANE and its potential 
severity, intravenous zanamivir was given after 4 days of oral 
oseltamivir.  The patient did not have any adverse effects and 
demonstrated a full neurological recovery. This virus may 
re-emerge in the coming months.11 For the vast majority of 
children it appears to have been a mild even asymptomatic 
infection, however monitoring is required to assess the 
prevalence of neurological sequelae of this particular strain 
of influenza.
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